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Abstract 
Cyclophosphamide (CYP) was one of the first chemotherapy drugs developed and used to 
treat several types of cancer, by disrupting proliferative cells. Unfortunately, CYP is unable 
to differentiate between cancerous cells and healthy cells turning over which ultimately kills 
normally functioning cells, including those of the taste system. This loss of taste cells may 
result in dysgeusia (altered sense of taste), hypogeusia (reduced taste ability) or ageusia 
(inability to detect any tastes), eventually leading to malnutrition and poor prognosis for 
patients. The notch signaling pathway is one of the most important pathways involved in the 
differentiation and fate of neural stem cells (Hitoshi et al., 2002). A previous study looked at 
genes expressed in developing circumvallate taste cells and found that notch signaling 
remains active in adult mice to determine cell lineage as the sensory cells are continuously 
replaced (Seta, Seta, & Barlow, 2003). The current research uses immunohistochemistry to 
identify the presence of notch signaling following injury by CYP. It was hypothesized that if 
Notch1 is involved in taste cell replacement, we predict the Notch1 signal should be 
amplified following challenge by cyclophosphamide. 
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Introduction 
Cancer and Cyclophosphamide (CYP) 
Cancer is the leading cause of death in all developed countries and the second in 
developing (Jemal et al., 2011). Several treatment options are available for the numerous 
types of cancer including chemotherapy and radiation treatment. CYP is one of the oldest 
forms of chemotherapy and is now one of the most 
commonly administered anticancer drugs. CYP is 
an alkylating drug that is mainly used to treat 
malignant lymphomas, leukemias, carcinomas of 
the ovary, and breast cancer (de Jonge, Huitema, 
Rodenhuis, & Beijnen, 2005). CYP (Figure 1) is a 
prodrug, which means it is administered in an 
inactive form and subsequently metabolized in 
the liver by p450 cytochrome oxidase into its 
active products. CYP is initially broken down into the unstable product 4-
hydroxycyclophosphamide, which tautomerizes to aldophosphamide. Aldophosphamide is 
then converted into the nontoxic compound carboxy phosphamide and the active, toxic, 
compounds acrolein and phosphoramide mustard. Most of aldophosphamide is converted into 
these cytotoxic products which is how CYP exerts its detrimental effects. Acrolein is an 
unsaturated aldehyde compound that is cytotoxic along with phosphoramide mustard. 
Phosphoramide mustard manifests its toxicity by creating both intra- and interstrand cross-
links in DNA during the S-phase (de Jonge et al., 2005). These cross-links inhibit DNA 
replication and further cell proliferation, ultimately leading to apoptosis, or programmed cell 
death. Although CYP is great at targeting rapidly proliferating cells, it cannot differentiate 
between healthy, proliferating cells and cancerous ones. The prognosis of the patient’s 
Figure 1. Mechanism of CYP metabolism. Identifying 
the pathway from inactive cyclophosphamide (black 
box), metabolism by cytochrome P-450 in the liver, and 
further metabolism into its active, cytotoxic and 
alkylating compounds acrolein and phosphoramide 
mustard, respectively (red boxes). Adapted from Emadi, 
Jones, & Brodsky, 2009) 
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disease largely depends on the efficacy of the drugs but the side effects cannot be overlooked. 
It was reported that 40% of cancer patients hospitalized suffer from malnutrition (Comeau, 
Epstein, & Migas, 2001). Loss of taste because of the chemotherapy treatment can result in a 
reduced appetite in the patient and an overall reduced quality of life. This leads to 
malnutrition and further dietary deficiencies ultimately causing more severe health problems. 
Overview of the Taste System 
Taste is one of our chemical senses that allows us to distinguish between healthy, 
nutritious foods and poisonous, harmful foods. Through evolution we have learned to reject 
bitter substances due to their relation to bitter-tasting poisonous compounds produced by 
plants and animals. We have also learned that sour tasting compounds can indicate something 
that is rotten, such as fruit, or acidic. The rest of the typically distinguished tastes are sweet, 
savory (umami) and salty (Barlow, 2015). Taste has proven to be an imperative sense 
throughout evolution which is why experiencing hypogeusia (decreased sensitivity), 
dysgeusia (distortion of taste), or ageusia (absence of taste) can potentially be fatal. 
The taste system is a chemical sensory system that is composed of taste buds 
containing taste sensory cells, which are located throughout the oral cavity and pharyngeal 
cavities. Taste buds are innervated by cranial nerves VII, IX, and X. Most taste buds on the 
tongue’s surface are part of specialized papillae called fungiform (FF) (Figure 2), 
circumvallate (CV) (Figure 2), or foliate taste papillae. Within each circumvallate and foliate 
taste papillae lie hundreds of taste buds that contain the specialized taste sensory cell (TSCs). 
Each FF taste papillae contains one taste bud made up of a cluster of cells. Each taste bud 
contains roughly between 50-100 TSCs that are differentiated into type I, II, and III cells 
(Barlow, 2015; Barlow & Ophir, 2015; Hamamachi, Asano-Miyoshi, & Emori, 2006; Yee et 
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al., 2013; Seta, Toyono, Kataoka, Toyoshima, 2005). Each taste cell type is morphologically 
and functionally different.  
Taste Cell Types. The most common, type I cells, are 
thought to be salt detector cells. They also the glial-like cells 
for the taste system because they appear to clear 
neurotransmitters and ensheath Type II and III taste cells with 
lamellar processes (Perea-Martinez, Nagai, & Chaudhari, 
2013; Barlow & Ophir, 2015). Type I cells can be identified 
by their expression of NTPDase2, which converts ATP to 
ADP. This is likely due to their neurotransmitter clearance 
mechanism. Type II cells are the sweet, bitter, and umami (savory) detectors. Type II cells 
can be identified by the expression of PLCβ2, which is involved in the g-protein-coupled 
receptor cascade. These cells have been shown to use ATP as neurotransmitters to send 
signals to sensory nerves. They do, however, lack regular presynaptic specializations and 
freely release their ATP molecules instead of enclosed in vesicles (Finger et al., 2005; 
Chaudhari, 2014). This supports the neurotransmitter clearing capabilities of Type I cells. 
Type III cells are sour detectors and appear to be most neuron-like, due to their formation of 
traditional synapses onto sensory nerve fibers of cranial nerves VII and IX. They can be 
identified by their expression of the SNAP-25 molecule, which is part of the SNARE 
complex (Barlow, 2015). 
Development 
Developmental pathways and signaling mechanisms govern when, where, and how 
quickly the TSCs arrive at their specific location. Taste bud development and innervation is 
well known in rodents and is said to begin at embryonic (E) day 11 in mice, where the tongue 
Figure 2. Diagram of tongue 
morphology. CV papilla (red box), 
located at the posterior, houses taste buds 
(green boxes). FF papillae, located at 
anterior two-thirds of tongue (blue box), 
house single taste bud (purple box). 
Adapted from Barlow, 2015. 
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rudiment forms and is covered by a homogenous epithelial bilayer (Kapsimali & Barlow, 
2013). By E12-12.5, taste placodes appear as foci of columnar epithelia in locations where 
fungiform and circumvallate papillae will form. At E14.5, invagination is evident to create 
taste papillae with distinct mesenchymal cores. Finally, taste nerve fibers reach and then 
penetrate the taste epithelium. It had been previously thought that innervation was required 
for taste bud development, however, we now know this is not the case. Barlow, Chien, and 
Northcutt (1996) elucidated that innervation is independent of taste bud development in rats 
and other mammals. They found that taste papillae or their primordia form in the epithelium 
prior to contact by neurites in vivo. They also found that the cranial nerve fibers (VII, IX, and 
X) that innervate the taste buds grow directly to the fungiform papillae, which suggests that 
the taste bud primordia may attract these nerves via a chemical cue (Barlow et al., 1996). The 
current understanding of taste bud development is that, embryonically, taste bud development 
is nerve-independent, but postnatally during differentiation of taste bud cells, innervation is 
required (Kapsimali & Barlow, 2013). At birth, taste precursor cells within the taste buds 
express embryonic markers, such as Shh, Sox2, and keratin-8 (K8), in the absence of 
innervation (Luo, Okubo, Randell, & Hogan, 2009). They do not, however, express any 
differentiated cell markers. The first postnatal week was shown to be a crucial time point for 
TSC differentiation in circumvallate papillae. Even when there was damage and regrowth of 
the innervated circumvallate papillae prior to complete differentiation, the resulting number 
of taste buds in the epithelium was permanently decreased. During this week, they will begin 
to express specific taste cell type markers indicating differentiation (Kapsimali & Barlow, 
2013; Barlow, 2015). 
Taste Cell Lifespans. The focus of the current research was on the TSC replacement 
cycle that occurs in adult mice circumvallate papillae. Many cell-signaling pathways are at 
work throughout the life of the animal regarding taste cell turnover. Parea-Martinez et al. 
10 
 
(2013) estimates that the population made up of neither Type II cells nor Type III cells, 
mainly Type I cells and undifferentiated or immature cells have half-lives of 8 and 24 days, 
respectively. Type II cells have a half-life of 8 days and Type III cells have a half-life of 22 
days (Perea-Martinez et al., 2013). Normally, due to the constant replacement of TSCs, there 
is a varied number of taste cells that are mature, immature, and sloughing off at any one time 
in the taste bud. Approximately 60-70% of the TSC population are differentiated cells, about 
20-30% of cells are undergoing differentiation, and about 10% of cells are undergoing 
apoptosis due to age (Barlow, 2015). 
 Taste cell Development/Replacement. TSCs come from a taste progenitor pool 
located in a basal layer just outside of the taste bud and in areas adjacent to the taste buds 
(Gaillard & Barlow, 2011). These cells are basal keratinocytes (Type IV cells) that appear to 
be transit amplifying cells that move up along the basal lamina. They can be identified by 
their expression of keratin-5 (K5+) and keratin-14 (K14+), which are intermediate filament 
proteins necessary for epithelial cell structure. Depending on β-catenin expression by these 
K5/K14+ cells, they will either end up as non-taste epithelium (low β-catenin expression) or 
differentiated TSCs (higher β-catenin expression) (Castillo et al., 2014; Gaillard & Barlow, 
2011; Okubo, Clark, & Hogan, 2009). Cells with higher β-catenin expression and subsequent 
expression of Sonic Hedgehog (Shh) are postmitotic taste cell precursors that will ultimately 
become differentiated TSCs. What dictates which type of TSC the precursors differentiate 
into is the level of this β-catenin expression. Within these higher β-catenin expressing 
K5/K14+ cells, relatively high β-catenin expression leads to Type I cells, mid β-catenin 
expression leads to Type II cells, and low β-catenin leads to Type III cells. Finally, the low 
level of β-catenin expression in the non-differentiated cells results in expression of keratin-13 
(K13) which are differentiated keratinocytes that will end up as non-taste epithelium 
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surrounding the taste bud and making up most of the tongue surface (Castillo et al., 2014; 
Gaillard & Barlow, 2011; Okubo et al., 2009). 
Notch Signaling Pathway 
Overview. The Notch signaling pathway is highly implicated in development 
throughout the nervous system, and specifically in the cell fate decisions (Seta et al., 2003). 
Notch is an evolutionarily conserved cell-cell signaling pathway that is composed primarily 
of transmembrane surface receptor proteins and membrane-bound ligands that are expressed 
on its neighbors that will ultimately activate the signaling cascade. Notch ligands have been 
shown to contain epidermal growth factor (EGF) repeats that appear to be necessary for 
proper binding to the transmembrane receptor protein. The initial two ligands shown to 
contain EGF repeats that bonded with the notch receptor were Delta and Serrate (Rebay, 
Fleming, Fehon, R. G. Cherbas, & P. Cherbas, 1991). However, years later it was shown that 
another ligand named Jagged can also bind to the notch receptor and that it contains EGF 
repeats (Lindsell, Shawber, Boulter, &Weinmaster 1995; Guarnaccia, Pintar, &Pongor, 2004; 
Guruharsha, Kankel, & Spyros, 2012).  
 Notch1 Signaling Cascade. Notch1 signaling begins by the signaling cell’s 
membrane-bound ligand, a Delta, Serrate, or Jagged, binding to the receiving cell’s 
transmembrane Notch1 receptor protein. Following ligand binding, intracellular γ-secretase is 
recruited to cleave the Notch intracellular domain (NICD). Then, the NICD translocates to 
the nucleus, where it begins to directly influence transcription via binding proteins such as 
protein recombining binding protein (RBPJ, or CBF1). Binding of RBPJ then activates 
repressor type Hes genes. Hes binds directly to the promoter region of Mash1 inhibiting 
expression and prevents certain neural differentiation (Seta et al., 2003; Guruharsha et al., 
2012). This implies that when Hes1 is downregulated, Mash1 expression upregulates and the 
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cell is driven toward a neuronal fate (Seta et al., 2003). This result occurs in the presence of 
the expression of Notch1. Notch1 is one of the three Notch homologs (1-3) identified in 
mammals (Lindsell et al., 1995) that are involved in development. Notch1 has been shown to 
be essential due to necessary cell-cell signaling and influence on downstream gene-
expression. When Notch1 expression is disrupted, lethality occurs very early, before 11.5 
days of gestation (Lindsell et al., 1995). Interestingly, the neural fate for developing cells is 
dependent on multiple Hes genes, as well. Another route for cell differentiation and 
regulation operates by inhibition of Hes1 via Hes6 activation, which leads to activation of 
Mash1 expression and further differentiation. Activation via the latter pathway has been 
shown to differentiate neuronal-like Type II and III cells, whereas via the former, support or 
Type I cells prevail (Seta et al., 2003). 
The fact that Notch1 acts to inhibit differentiation via activation of Hes1 and further 
suppression of Mash1 largely contributes the results of the current study. Our findings 
indicate that around day 4 post-injection, there is a decrease in Notch1 labelling followed by 
a gradual increase. This increase in Notch1 could therefore be indicating the decreasing level 
of specific Type II and Type III TSC differentiation and an increase in Type I TSC 
differentiation. 
Hypothesis 
It was hypothesized that if Notch1 is involved in taste cell replacement, we predict the 
Notch1 signal should be amplified following challenge by CYP. 
Materials and Methods 
Subjects 
Male C57BL/6J mice were obtained from Jackson Laboratory (Bar Harbor, ME). 
Mice were at least 8 weeks old and weighed between 23-26g at the beginning of the 
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experiment. All procedures were approved by the Institutional Animal Care and Use 
Committee at the University of Vermont, protocol number 14-003. The experiment was 
designed to minimize the amount of mice required to test the experimental question. 
Chemical Reagents 
CYP (Cyclophosphamide monohydrate, 97%) was obtained from Acros Organics (New 
Jersey, USA). 
Tissue Preparation 
The cellular morphology of circumvallate (CV) taste papillae and taste buds of the 
tongue were examined at days 0 (saline), 3, 4, 5, 6, 7, 8, and 10 following a 75 mg/kg CYP 
injection. Perfusions were done using PBS-heparin followed by 4% paraformaldehyde in PBS 
(Electron Micros-copy Sciences, Hatfield, PA USA) and the tongues were harvested for 
analysis. Following perfusion, tongues were cryoprotected using a 30% sucrose solution (24-
36 hrs) and then and kept at -80º C. CV tongue blocks were cryo-sectioned at a thickness of 6 
µm. Every 8th section was mounted on one slide to ensure accurate quantitative evaluation of 
taste buds and to prevent overlapping counts. Tissue collection began at the first sight of the 
CV papillae, which was viewed under a dissecting scope. Slides kept at -20º C. 
Immunohistochemistry of Notch1 labeling 
Notch1 primary polyclonal antibody (Catalog # ab65297; Abcam, Cambridge, UK) 
was used at 1:100 dilution for incubation at 4º C overnight and the secondary antibody was 
Alexa 546 goat anti-rabbit used at 1:1000 dilution (Thermo Fisher, Waltham, MA). All slides 
were counterstained using Sytox green (1:30,000; S7020, Molecular Probes, Eugene, OR) as 
a nuclear marker. 
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Statistical Analysis 
All statistical analyses were done using SPSS software (SPSS Statistics, version 24, 
IBM Corporation, Chicago, IL, USA) and Graphpad Prism 7 software. Analysis of variance 
(ANOVA) procedures were used to compare the effects of CYP on Notch1 expressing cells 
of the taste buds between each timepoint post-injection (PI). The independent variable, days 
PI (8 levels), was treated as a between subject variable. 
Image Capture Analysis 
All images were captured using a Zeiss Axioskop2 with 20x magnification and with a 
63x water immersion with a Photometric Cool SNA EZ camera and NIS Elements acquisition 
and imaging software. Cell counts were taken using ImageJ (NIH, Bethesda, MD, USA). 
Results 
Overall, the results of this study identify a pattern in Notch1 signaling over the course 
of 10 days PI. At day 0 CYP post injection, we should expect there to be uniform expression 
of Notch1 throughout the taste bud. This indicates a basal level of Notch1 expression 
throughout the taste bud as new differentiating cells replace the cells due to normal attrition 
from aging. This is exactly what is observed. In Figure 3, Notch1 is expressed uniformly 
throughout many cells. Therefore, days post-CYP injection, we should expect to see a drop in 
Notch1 expression because the cells are dying off. An observable and statistically significant 
drop in the number of labelled Notch1 taste cells appears at 4 days PI (Figure 4), which 
subsequently begins to increase back towards the normal level. Figure 5 shows that the 
number of labeled cells has increased gradually over the next 6 days.  
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Notch1 Localization  
The Notch1 labeling at day 0, the labeling appears more localized to the nuclear 
region of the cells and less on the cell membrane. At days 4 and 10, the Notch1 labeling 
appears significantly more in the cell membrane and is less localized in the nuclear region. 
Overall, the amount of labeling in day 4 CYP is Significantly lower than observed in Day 0 
CYP mice. 
 
 
 
Figure 3. Day 0 CYP; all taken at 20x. A) Original nuclear labeled (Sytox green). B) 
Colorized green nuclear labeled. C) Original Notch1 labeled cells. D) Colorized red 
Notch1 antibody. E) Merged, orange-colored cells show double labeled for Notch1 
appearing in the nucleus (red arrow), as well as around the nucleus on the cell 
membrane (white arrow). Uniform amount of notch signaling throughout taste bud 
indicating basal amount of activation and therefor normal activation and replacement. 
A 
B
 
C
 
D
 
E 
16 
 
 
 
 
 
 
 
 
 
 
Figure 4. Day 4 CYP; all taken at 20x. A) Original nuclear labeled (Sytox green). B) 
Colorized green nuclear labeled. C) Original Notch1 labeled cells. D) Colorized red 
Notch1 antibody. E) Merged, Notch1 labeling seen almost exclusively in cell membranes. 
Severely diminished amount of Notch1 labeling throughout the taste bud indicating low 
levels of expression of Nocth1 due to CYP challenge. 
A 
B 
C 
D 
E
E 
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Statistics 
A one-way ANOVA was performed that identified a statistically significant effect 
between the experimental timepoints. Post hoc comparisons (Sidak) comparing all days to 
day 0 PI indicated that at days 3 and 4, there were significantly fewer (P<0.05) Notch1 
labeled taste cells out of the total number of TSCs per taste bud compared to the other days 
(Fig. 6). After day 4 the Notch1 labeled slowly increased, returning to baseline levels. 
 
Figure 5. Day 10 CYP. Panel A) Taken at 20x. Composed of originally labeled (black 
and white), colorized (green nuclear label, red antibody label), and larger merged image 
(at right). Panel B) Taken at 63x with water immersion lens. Composed of originally 
labeled (black and white), colorized (green nuclear label, red antibody label), and larger 
merged image (at right). Bottom-right merged image shows 63x magnification of the 
above corresponding image. Here, three cells (arrows) are labeled on their cell membranes 
(red). The shape of the TSCs is also evident, as they have an elongated shape that points to 
the apical end and extends towards the basilar end. The extent to which the cells extend to 
each end depends on the type of TSC. It is unclear from the image what type of taste cell 
is labeled. 
18 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Mean (± SEM) of labeled Notch1 cells in CV taste buds. Notch1-positive 
cells in CV shows significant decrease following CYP injection indicating severe loss of 
TSCs. Slowly, notch labeling increases over the course of 10 days. There was a significant 
decrease in the number of labeled cells between day 0 (saline) and day 3, and day 0 and 
day 4 (* P<0.05). 
* 
* 
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Discussion 
Notch signaling has been evolutionarily conserved and plays an imperative role in 
determining cell fate in several types of developmental processes in many organisms 
(Guruharsha et al., 2012; Seta et al., 2003). Previous research has implicated Notch signaling 
in taste cell development and replacement. Different genes responsible for taste bud and TSC 
development and taste cell 
replacement have also been identified 
including Hes1, Hes6, Notch1-4, and 
Mash1 (Seta et al., 2003; Barlow, 
2015). Embryologically, the process 
by which taste buds develop has been 
shown to be nerve-independent, but 
that taste cell differentiation is nerve-
dependent. As the animal matures, 
taste cells die and must be replaced. 
Many systems involved in 
embryologic development also take 
part in regular taste cell replacement 
throughout adult life, such as 
Wnt/β-Catenin, Sonic Hedgehog 
(Shh), and Notch. In adult animals, 
it has been shown that there is a 
progenitor cell population located 
in the basal layer and adjacent taste epithelium of mature taste buds. When activated, 
signaling pathways cause immature, nonmitotic cells to migrate into the taste bud and 
Figure 7. Taste cell renewal in adult mice. A) All 3 types of 
taste cells in adult taste buds. Basal layer (green) shows where 
progenitor pool is located as well as those adjacent to taste bud. 
Basal keratinocytes (green) show asymmetric division (curved 
arrow indicated keratinocyte replenishment). Differentiated 
keratinocytes (orange) are non-taste cells. Post-mitotic taste 
precursor cells (purple) eventually differentiate into taste cells 
(type I, II, and III). B) Notch activity would be indicated where 
Mash1 expression is indicated, depending on what type of Hes 
activity is occurring. Adapted from Barlow, 2015. 
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differentiate to end up in their final phenotype (Figure 6) (Barlow, 2015; Gaillard & Barlow, 
2011; Okubo et al., 2009; Miura, Scott, Harada, & Barlow, 2014). 
The previous mention of the effects of Hes1 on Hes6 may explain the observed trend 
in Figure 6. When Notch1 becomes active and further activates Hes1 in the developing mouse 
nervous system, it was shown that Mash1, which encodes a developmentally relevant Mash1 
protein, is inhibited. This eventually leads the cells to a glial fate, which could translate to 
Type I TSC differentiation. When a non-repressor type Hes gene is activated, Hes6, Mash1 is 
activated and leads to neuronal differentiation, which would translate to Type II and III 
differentiation. The decrease in Notch1 labeling at day 4 and then the subsequent increase 
could be evident of this system shifting from differentiating more neuronal type TSCs (low 
Notch1 expression) to more glial-like TSCs (higher Notch1 expression) (Bae, Bessho, Hojo, 
& Kageyama, 2000).  
These results can further be analyzed to show the cycles of activation of Notch1 
signaling, which gives crucial insight into the timing of the taste cell replacement cycle. We 
could expect to see decreased levels of Mash1 signaling along with the increase in Notch1 
signaling due to the suppressing effect of Hes6. This study can be taken at a larger scale to 
highlight important points along the taste cell replacement cycle that could be 
pharmacologically targeted. This research is comparable to that by Mukherjee, Carroll, 
Spees, and Delay (2013), which indicated a drop in the number of BrdU-positive (S-phase 
marker for mitosis), proliferating cells in the CV and FF taste papillae. In response to this, the 
protective agent amifostine was injected before CYP administration and a significant increase 
in the number of proliferative cells was observed. The current research could be used to 
identify a crucial time point to intervene pharmacologically. These data therefore suggest an 
important role of notch signaling in taste cell replacement. 
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Future Directions 
To more thoroughly identify Notch1 signaling in the taste cell replacement cycle, the current 
study should be replicated and carried out to at least 30 days post-injection. This would allow 
for at least one full cycle of taste cells to regrow following challenge by cyclophosphamide. 
The trends in Notch1 activation would also be clearer and more crucial points could be 
elucidated for potential treatment intervention. To observe the activity of Mash1 in relation to 
Notch1 during TSC replacement, double labeling against Mash1 and Notch1 should be 
performed. If the nature of these genes withstands in the taste system as it does in the 
developing mouse nervous system, an inverse trend should be observed as the TSCs grow 
back. Another important avenue to explore and to further support the Mash1 hypothesis, 
would be to label specific TSC markers, such as PLCβ2 and SNAP-25. This would give 
insight into which TSCs are developing at which timepoints in relation to Notch1 and Mash1 
expression. 
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